Financial results - AMAMEDICA S.R.L.

Financial Summary - Amamedica S.r.l.
Unique identification code: 15149516
Registration number: J05/57/2003
Nace: 8622
Sales - Ron
89.818
Net Profit - Ron
71.128
Employee
1
The most important financial indicators for the company Amamedica S.r.l. - Unique Identification Number 15149516: sales in 2023 was 89.818 euro, registering a net profit of 71.128 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Amamedica S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 781 5.981 44.457 60.819 58.304 61.152 62.476 67.464 101.551 89.818
Total Income - EUR 960 5.981 44.460 106.169 58.310 61.152 92.640 67.574 119.755 93.863
Total Expenses - EUR 5.122 1.845 2.624 63.017 12.268 15.122 48.393 16.923 17.396 22.125
Gross Profit/Loss - EUR -4.161 4.136 41.835 43.152 46.042 46.030 44.247 50.651 102.360 71.738
Net Profit/Loss - EUR -4.190 3.957 40.501 39.967 44.293 44.195 41.468 48.624 98.767 71.128
Employees 0 0 0 0 0 0 0 0 0 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -11.3%, from 101.551 euro in the year 2022, to 89.818 euro in 2023. The Net Profit decreased by -27.340 euro, from 98.767 euro in 2022, to 71.128 in the last year.

Check the financial reports for the company - Amamedica S.r.l.

Rating financiar

Financial Rating -
Amamedica S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Amamedica S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Amamedica S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Amamedica S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Amamedica S.r.l. - CUI 15149516

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 61.778 60.598 60.931 42.492 30.587 54.398 32.462 19.151 12.374 42.396
Current Assets 121 6.092 5.529 26.276 60.387 79.157 63.322 122.422 34.816 67.460
Inventories 0 0 0 0 0 0 0 0 0 2.378
Receivables 24 5.754 26 493 484 0 413 404 6.032 64.227
Cash 97 338 5.503 25.783 59.903 79.157 62.909 122.017 28.784 854
Shareholders Funds -17.080 -13.266 27.415 66.919 90.558 133.000 94.613 141.139 61.657 80.699
Social Capital 45 45 89 88 172 169 165 162 162 162
Debts 78.979 79.956 39.045 1.850 416 556 1.171 433 5.564 49.126
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 67.460 euro in 2023 which includes Inventories of 2.378 euro, Receivables of 64.227 euro and cash availability of 854 euro.
The company's Equity was valued at 80.699 euro, while total Liabilities amounted to 49.126 euro. Equity increased by 19.229 euro, from 61.657 euro in 2022, to 80.699 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Amamedica S.r.l.

Comments - Amamedica S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.